Development of biosimilars in an era of oncologic drug shortages

Acute and chronic shortages of various pharmaceuticals and particularly of sterile injectable products are being reported on a global scale, prompting evaluation of more effective strategies to manage current shortages and development of new, high-quality pharmaceutical products to mitigate the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Edward, Subramanian, Janakiraman, Anderson, Scott, Thomas, Dolca, McKinley, Jason, Jacobs, Ira A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484646/
https://www.ncbi.nlm.nih.gov/pubmed/26150698
http://dx.doi.org/10.2147/DDDT.S75219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484646/
https://www.ncbi.nlm.nih.gov/pubmed/26150698
http://dx.doi.org/10.2147/DDDT.S75219

Ejemplares similares